Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients

被引：0
|
作者：
Khamash, H. [1 ]
Mannon, R. [1 ]
Hanaway, M. [1 ]
Gaston, R. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1555
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [41] Elevated De Novo Donor Specific Antibody After Alemtuzumab Induction in Renal Transplant Recipients.
    Fabbri, K.
    Descourouez, J.
    Jorgenson, M.
    Redfield, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 619 - 619
  • [42] Alemtuzumab Induction in Sensitized, Kidney Re-Transplant Recipients
    Shaffer, I.
    Hale, D.
    Moore, D.
    Schaefer, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 251 - 251
  • [43] Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.
    Yakubu, I.
    Masters, B.
    Ravichandran, B.
    Sparkes, T.
    Moss, M.
    Rasetto, F.
    Jonchhe, S.
    Thomas, B.
    Costa, N.
    Leeser, D.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 614
  • [44] Incidence of cytomegalovirus in cardiac transplant recipients receiving induction immunosuppression with antithymocyte globulin
    Jewani, Poonam K.
    Pouch, Stephanie M.
    Kissling, Kevin T.
    CLINICAL TRANSPLANTATION, 2018, 32 (11)
  • [45] Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
    Kitto, Brent
    Thai, Steven
    Baetz, Brooke
    Patel, Hamang M.
    Mandras, Stacy A.
    Desai, Sapna
    Krim, Selim R.
    OCHSNER JOURNAL, 2021, 21 (02): : 133 - 138
  • [46] Elevated de novo donor specific antibody after alemtuzumab induction in renal transplant recipients.
    Jorgenson, Margaret
    Fose, Jillian
    Redfield, Robert
    Fabbri, Kassandra
    PHARMACOTHERAPY, 2016, 36 (07): : E103 - E104
  • [47] Combined Antithymocyte Globulin (ATG) and Rituximab (RTX) Induction in African American (AA) Kidney Transplant Recipients.
    Patel, S. J.
    Kuten, S.
    Pham, C.
    Knight, R.
    Hobeika, M.
    Nguyen, D.
    Graviss, E.
    Yi, S.
    Eagar, T.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 819 - 820
  • [48] Basiliximab vs Antithymocyte Globulin Induction with Early Steroid Withdrawal in Kidney Transplant Recipients: Early Rejection Outcomes
    Szczepanik, A.
    Burrelli, C.
    Bixby, A.
    Yadav, K.
    Chavin, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 908 - 909
  • [49] Renal Allograft Outcome and Infectious Complications Following Antithymocyteglobulin and Alemtuzumab Used as Induction in Kidney Transplantation
    Jiamjariyaporn, T.
    Lumlertgul, D.
    Manoyos, A.
    Bunnachak, D.
    Opascharoensuk, V.
    Noppakhun, K.
    Suteeka, Y.
    TRANSPLANTATION, 2014, 98 : 643 - 644
  • [50] Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
    Jankovic, J.
    Pascual, M.
    Venetz, J. -P.
    Nseir, G.
    Meylan, P.
    Manuel, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 323 - 323
12345